Strategic Collaborations Driving Expanded Access And Faster Diagnostics In Newborn Health Is Affecting The Direction Of The Neonatal Point Of Care Testing Market
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Expansion Is Expected For The Neonatal Point Of Care Testing Market Over The Forecast Period?
The neonatal point of care testing market has seen considerable expansion in its size over recent years. It is projected to expand from $1.32 billion in 2025 to $1.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.5%. The historical growth can be attributed to heightened awareness of neonatal mortality, the adoption of rapid testing devices in hospital environments, governmental support for neonatal care, the proliferation of maternity clinics, and technological improvements in bedside testing methods.
The market for neonatal point of care testing is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $2.59 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.3%. Factors contributing to this growth during the projected period include the emergence of AI-powered diagnostic tools, the integration of cloud technology for managing neonatal data, the availability of portable and compact point-of-care instruments, a rise in collaborations between private and public sectors for newborn health, and the development of neonatal healthcare infrastructure in developing economies. Key trends anticipated in this forecast timeframe encompass AI-driven neonatal diagnostics, point-of-care platforms utilizing cloud technology, mobile testing apparatus, analysis of data in real-time, and the incorporation of IoT for monitoring newborns.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28277&type=smp
What Influential Factors Are Boosting The Neonatal Point Of Care Testing Market Demand?
The growing requirement for remote patient monitoring is projected to accelerate the expansion of the neonatal point of care testing market moving forward. Remote patient monitoring involves the delivery of healthcare services through technology, connecting patients with medical professionals from a distance. The need for remote patient monitoring is escalating due to the rising necessity for accessible and convenient medical attention, particularly for patients residing in remote or underserved regions. Neonatal point-of-care testing aids remote patient monitoring by providing immediate diagnostic results at the bedside, enabling healthcare providers to swiftly identify and manage critical conditions in newborns without the need for a central laboratory. For instance, in August 2023, according to Vivalink, a US-based healthcare technology company, a recent survey disclosed that 84% of current remote patient monitoring (RPM) users intend to expand their use in 2024, 45% of healthcare providers are utilizing RPM for acute monitoring in hospital-at-home programs, and 77% believe that RPM-based care will overtake traditional inpatient hospital care within the next five years. Thus, the increasing demand for remote patient monitoring is anticipated to propel the growth of the neonatal point of care testing market.
Which Segment-Based Categories Are Covered In The Neonatal Point Of Care Testing Market?
The neonatal point of care testing market covered in this report is segmented –
1) By Product: Instruments, Assay
2) By Test Type: Neonatal Bilirubin Testing, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, Other Test Types
3) By End-Users: Hospitals, Maternity And Specialty Clinics, Other End-Users
Subsegments:
1) By Instruments: Blood Gas Analyzers, Bilirubinometers, Glucose Meters
2) By Assay: Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Electrolyte Assays, Blood Gas Assays
Which Trends Are Influencing The Direction Of The Neonatal Point Of Care Testing Market?
Leading firms within the neonatal point of care testing market are concentrating on forging strategic alliances to more effectively reach new markets and expand their customer base. These alliances involve organizations combining their resources and specialized knowledge to accomplish common business objectives. As an illustration, in January 2025, QIAGEN, a Netherlands-based supplier of sample and assay technologies, formed a partnership with Genomics England, a genomic medicine firm located in the UK. This collaboration has facilitated the initiation of the Generation Study, a project set to sequence the genomes of 100,000 newborns across England to identify over 200 treatable genetic conditions. QIAGEN’s contribution will be providing distinct, clinically significant variant data for genes involved in the point-of-care sequencing test. Such data aims to expedite the interpretation and reporting of sequencing outcomes, thereby aiding in the earlier discovery and management of uncommon conditions. Commencing officially in October 2024, the study focuses on conditions potentially affecting approximately 3,000 newborns each year within the UK.
Who Are The Firms Contributing To The Neonatal Point Of Care Testing Market Ecosystem?
Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Dräger AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMérieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl
Access The Complete Neonatal Point Of Care Testing Market Report:
Which Region Accounts For The Highest Share Of The Neonatal Point Of Care Testing Market?
North America was the largest region in the neonatal point of care testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal point of care testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Neonatal Point Of Care Testing Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Neonatal Point Of Care Testing Market 2026, By The Business Research Company
Pediatric And Neonatal Testing Kit Market Report 2026
Prenatal Testing And Newborn Screening Market Report 2026
Prenatal And Newborn Genetic Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
